Outcome of COVID-19 in Patients with Myasthenia May Not Only Depend on the Immunologic Disease
IAR Journal of Medicine and Surgery Research · Volume 1, Issue 2 (2020) · pp. 11–12
Abstract
<jats:p>With interest we read the article by Camelo-Filho et al., (2020) about 15 patients with myasthenia gravis (MG) admitted to four hospitals in Sao Paolo because of an infection with SARS-CoV-2 (COVID-19). The authors found that most MG patients developed a severe course of COVID-19, such that 87% of the MG patients required transfer to the intensive care unit (ICU), that 73% required artificial ventilation, and that 30% of these patients died. We have the following comments and concerns.</jats:p>